Christopher Bettacchi MD in Dallas, Texas

Home Texas Dallas

Christopher Bettacchi MD has Infectious Disease as his primary medical specialty. Their primary office is: 3409 Worth St in Dallas, Texas.

They're a part of the: North Texas Infectious Diseases Consultants medical group which has around 11 members. You can call their office at 214-823-2533 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2001 (around 23 years of experience). They are listed as doing telehealth appointments.

Christopher J Bettacchi MD Office Phone and Directions

Christopher Bettacchi MD
North Texas Infectious Diseases Consultants
3409 Worth St
Dallas, Texas 75246
214-823-2533

Patient Ratings
Please rate your experience with Christopher Bettacchi MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 214-823-2533

Enter a starting address:

Healthcare Info for Christopher Bettacchi MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2001
The Primary Medical Specialty for Christopher Bettacchi MD is listed as: Infectious Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 23
PAC (PECOS ID)#: 7618914599
NPI #: 1083669543
NPI Created On: 05/23/2006
NPI Last Updated Listed as: 07/21/2010
Primary Taxonomy Code: 207RI0200X
License Number:
N6174
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Oscar Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Polish, Other, German, Amharic.

Services and Procedures include:

Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Injection, denosumab, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, ertapenem sodium, 500 mg
Injection, zoledronic acid, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787678425

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787678435

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787678443

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787678453

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787678465

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813492183

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803215673

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HIV

Name of Drug #1: DOVATO

Open Associated Drug #1: 49702-246-13

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803215675

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HIV

Name of Drug #1: DOVATO

Open Associated Drug #1: 49702-246-13

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803215715

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HIV

Name of Drug #1: DOVATO

Open Associated Drug #1: 49702-246-13

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803215727

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HIV

Name of Drug #1: DOVATO

Open Associated Drug #1: 49702-246-13

Infectious Disease Professionals in Dallas

1.
Cima Nowbakht

7777 Forest Ln
Dallas, TX
Id Specialists, P.a.

2.
Kavita Bhavan

2201 Inwood Rd
Dallas, TX
University Of Texas Southwestern Medical Center

3.
Susana Lazarte

2201 Inwood Rd
Dallas, TX
University Of Texas Southwestern Medical Center

4.
Susana Lazarte

5200 Harry Hines Blvd
Dallas, TX
University Of Texas Southwestern Medical Center

5.
Susana Lazarte

5151 Maple Ave
Dallas, TX
University Of Texas Southwestern Medical Center

6.
Susana Lazarte

6201 Harry Hines Blvd
Dallas, TX
University Of Texas Southwestern Medical Center

Providers in North Texas Infectious Diseases Consultants

1.Ashley Agura

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Physician Assistant

2.Mezgebe Berhe Md

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Infectious Disease

3.Christopher Bettacchi Md

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Infectious Disease

4.Devyani Deshpande

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Infectious Disease

5.Emma Dishner

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Infectious Disease

6.Erin Duhaime

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Physician Assistant

View all 11 members of North Texas Infectious Diseases Consultants medical group